2.78
price down icon2.80%   -0.08
pre-market  Vorhandelsmarkt:  2.77   -0.010   -0.36%
loading

Inmune Bio Inc Aktie (INMB) Neueste Nachrichten

pulisher
04:23 AM

What analysts say about INmune Bio Inc. stockOutstanding yields - PrintWeekIndia

04:23 AM
pulisher
02:28 AM

Is INmune Bio Inc. a good long term investmentOutstanding capital growth - PrintWeekIndia

02:28 AM
pulisher
Jul 24, 2025

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference - The Manila Times

Jul 24, 2025
pulisher
Jul 24, 2025

INmune Bio to present additional Phase 2 Alzheimer’s trial data - Investing.com Australia

Jul 24, 2025
pulisher
Jul 22, 2025

When (INMB) Moves Investors should Listen - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

INmune Bio Inc. Stock Analysis and ForecastHigh-yield trading alerts - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives INmune Bio Inc. stock priceRapid wealth accumulation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

Is INmune Bio Inc. stock overhyped or has real potentialFree Stock Selection with 300% Return - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

Why INmune Bio Inc. stock attracts strong analyst attentionInsider Strategy Insight - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How INmune Bio Inc. stock performs during market volatilityCapital Growth Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Cambridge Investment Research Advisors Inc. Makes New $180,000 Investment in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Jul 15, 2025
pulisher
Jul 15, 2025

What makes INmune Bio Inc. stock price move sharplyTop Momentum Stock Pick - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

INmune Bio Shares Collapse After Mixed Results from Alzheimer’s Drug Trial - MSN

Jul 12, 2025
pulisher
Jul 12, 2025

Where are the Opportunities in (INMB) - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 07, 2025

INmune Bio shares slide after Phase II Alzheimer’s trial misses endpoints - MSN

Jul 07, 2025
pulisher
Jul 06, 2025

INmune Bio reverses early gains after stock offering - MSN

Jul 06, 2025
pulisher
Jul 06, 2025

INmune Bio surges ahead of mid-stage trial readout for Alzheimer’s drug - MSN

Jul 06, 2025
pulisher
Jul 05, 2025

INmune Bio's Alzheimer's drug misses mid-stage goal, shares sink to record low - MSN

Jul 05, 2025
pulisher
Jul 04, 2025

'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday - Benzinga

Jul 04, 2025
pulisher
Jul 03, 2025

INmune Bio's Alzheimer's drug falls short of mid-stage study goal, shares tumble - MSN

Jul 03, 2025
pulisher
Jul 02, 2025

XPro™'s Subgroup Success: A Silver Lining in INmune Bio's Alzheimer's Setback - AInvest

Jul 02, 2025
pulisher
Jul 02, 2025

INmune Bio's $19M Funding: A Lifeline or a Launchpad for Breakthroughs? - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

INmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial - MSN

Jul 01, 2025
pulisher
Jul 01, 2025

(INMB) Proactive Strategies - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jul 01, 2025

INmune Bio Shares Fall After Downgrade From BTIG Research - MarketScreener

Jul 01, 2025
pulisher
Jul 01, 2025

INmune Bio Shares Plunge After Alzheimer's Trial Misses Target - Finimize

Jul 01, 2025
pulisher
Jul 01, 2025

INmune Bio (INMB) Faces Significant Downgrade by Scotiabank | INMB Stock News - GuruFocus

Jul 01, 2025
pulisher
Jul 01, 2025

A Drug-Trial Stock Sale - Bloomberg.com

Jul 01, 2025
pulisher
Jun 30, 2025

INmune Bio stock downgraded by Raymond James after Alzheimer’s trial miss - Investing.com Australia

Jun 30, 2025
pulisher
Jun 30, 2025

Inmune Bio Secures $18.9 Million in Stock Offering - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

Clinical-Stage Biotech INmune Bio Secures $19M Through Strategic Share Offering - Stock Titan

Jun 30, 2025
pulisher
Jun 30, 2025

Raymond James Downgrades INmune Bio to Market Perform From Outperform; Shares Fall - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Inmune Bio’s Phase 2 Trial Shows Promise in Alzheimer’s - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio shares tumble as Alzheimer’s drug falls short in mid-stage trial - Proactive Investors

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio's XPro: A Missed Milestone or a Hidden Gem in Alzheimer's Drug Development? - AInvest

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial By Stocktwits - Investing.com India

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio’s Stock Tanks: Worth Considering? - timothysykes.com

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio’s Alzheimer’s drug shows benefit in inflammatory subset - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio’s Alzheimer’s drug shows benefit in inflammatory subset By Investing.com - Investing.com UK

Jun 30, 2025
pulisher
Jun 30, 2025

INmune Bio Reports Key Findings from Phase 2 MINDFuL Trial of XPro™ in Early Alzheimer’s Disease - The Manila Times

Jun 30, 2025
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):